• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
Endogenex

Endogenex

Bringing New Energy to the Treatment of Type 2 Diabetes

  • T2D
  • ReCET
  • Patients
  • Clinical Providers
  • About Us
    • News
    • Contact
  • ReCET Study

Stacey Pugh Combines Bedside Background with Market Experience to Affect Change for Type 2 Diabetes

With a background as a trauma nurse and experience running clinical research programs, Stacey Pugh brought quite a bit of patient-focused experience with her when she shifted to industry. After several roles in the neurovascular space, now she’s leading the charge at Endogenex, which is using pulsed electric fields to treat Type 2 Diabetes. She and host, Geoff Pardo, talk about a medical officer’s first experience doing sales, the challenges in affecting change management in primary care, funding businesses with SPACs, and more.

Originally appeared on Medtech Talk on April 25, 2023

Listen below:

Previous Post:EndogenexEndogenex™ Appoints Christopher Sorli as Chief Medical Officer
Next Post:Endogenex™ Receives IDE Approval to Initiate Pivotal Clinical StudyEndogenex

* Caution: Exclusively a clinical investigational device. Limited by federal (or United States or similar) law to investigational use. Not for sale in any geography.

Please refer to your physician for additional information on the ReCET Procedure, ReCET System, and related risks.

Endogenex, Inc.
13755 1st Avenue North #100
Plymouth, MN 55441
+1 763-251-6820
info@endogenex.com

References

Terms of Use

Privacy Policy

Cookie Policy

EndogenexTM and ReCETTM are registered trademarks of Endogenex, Inc. in the United States and other countries. Copyright © 2025 Endogenex, Inc. All rights reserved.

  • LinkedIn
  • X
  • Vimeo